PHARMACODYNAMICS, PHARMACOKINETICS, AND INTUBATION CONDITIONS AFTER PRIMING WITH 3 DIFFERENT DOSES OF VECURONIUM

被引:6
|
作者
HUEMER, G [1 ]
SCHWARZ, S [1 ]
GILLY, H [1 ]
WEINDLMAYRGOETTEL, M [1 ]
PLAINER, B [1 ]
LACKNER, F [1 ]
机构
[1] L BOLTZMANN INST EXPTL ANAESTHESIOL & RES INTENS,VIENNA,AUSTRIA
来源
ANESTHESIA AND ANALGESIA | 1995年 / 80卷 / 03期
关键词
D O I
10.1097/00000539-199503000-00018
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
The effects of three different priming doses of vecuronium on pharmacokinetics, pharmacodynamics, and endotracheal intubation conditions were investigated. Forty-two patients were studied in two parts. Ln each part, 21 patients were allocated into three groups (n = 7/group) receiving 10, 15, or 20 mu g/kg vecuronium as a priming dose, followed by a 50- mu g/kg intubating dose 6 min later. In Part I, Train-of-Four (TOF) ratios and serum concentrations after priming were measured every minute up to the sixth minute. Onset time [from injection of the intubating dose to maximum depression of the first twitch (T1)], clinical duration (T1 return from maximum block to 25% of control), and recovery index (T1 recovery from 25% to 75% of control) were calculated and serum concentrations were determined up to 6 h after injection of the intubating dose. In Part II, the intubating dose was injected 4 min after priming, onset time was determined, and intubation conditions were scored. TOF ratio was significantly lower after priming with 20 mu g/kg at the fifth and sixth minutes (0.59 +/- 0.29 and 0.56 +/- 0.32; mean +/- 1 so) compared with the first minute (0.95 +/- 0.1). Recovery index was significantly increased after priming with 20 mu g/kg (23.2 +/- 6.6 min, P < 0.05) compared with 10 mu g/kg (9.2 +/- 4.8 min) and 15 mu g/kg (6.7 +/- 1.5 min). Between groups no differences in onset time, clinical duration, and pharmacokinetic variables were found. In Part II, onset time and intubating scores showed no significant differences between the groups. In conclusion, a priming dose of 10 mu g/kg followed by a 50-mu g/kg intubating dose 4 min later provides good intubation conditions within 1-2 min. Larger priming doses are not advantageous because they result in higher plasma levels and do not hasten onset time more than the smaller dose.
引用
收藏
页码:538 / 542
页数:5
相关论文
共 50 条
  • [1] PHARMACOKINETICS, PHARMACODYNAMICS AND INTUBATION CONDITIONS AFTER PRIMING WITH VECURONIUM
    HUEMER, G
    GILLY, H
    LACKNER, F
    ANESTHESIOLOGY, 1994, 81 (3A) : A1105 - A1105
  • [2] The Pharmacodynamics of Vecuronium in Chronic Renal Failure Patients: The Impact of Different Priming Doses
    Tarbeeh, Gehan A.
    Othman, Mahmoud M.
    RENAL FAILURE, 2012, 34 (07) : 827 - 833
  • [3] Pharmacodynamics after priming with two different doses of cistracurium
    Scheller, A
    Keller, P
    Keller, C
    Mitterschiffthaler, G
    Pühringer, FK
    ANESTHESIA AND ANALGESIA, 1999, 88 (02):
  • [4] INTUBATING CONDITIONS AFTER VECURONIUM AND ATRACURIUM GIVEN IN DIVIDED DOSES (THE PRIMING TECHNIQUE)
    MIRAKHUR, RK
    LAVERY, GG
    GIBSON, FM
    CLARKE, RSJ
    ACTA ANAESTHESIOLOGICA SCANDINAVICA, 1986, 30 (05) : 347 - 350
  • [5] The effect of different priming doses on the pharmacodynamics of cisatracurium
    Pühringer, FK
    Scheller, A
    Kleinsasser, A
    Löckinger, A
    Keller, P
    Raedler, C
    Keller, C
    ANAESTHESIST, 2000, 49 (02): : 102 - 105
  • [6] The influence of precurarization with different doses of atracurium and vecuronium on the pharmacodynamics of succinylcholine
    Blobner, M
    Schneck, HJ
    Busley, R
    Schneider, G
    JelenEsselborn, S
    Kochs, E
    ANESTHESIOLOGY, 1996, 85 (3A) : A848 - A848
  • [7] PHARMACODYNAMICS AND PHARMACOKINETICS OF 3 DIFFERENT DOSES OF URAPIDIL INFUSED IN HYPERTENSIVE PATIENTS
    KIRSTEN, R
    NELSON, K
    NEFF, J
    HAERLIN, R
    STEINIJANS, V
    RADTKE, HW
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 30 (05) : 549 - 552
  • [8] THE INFLUENCE OF ALFENTANIL ON THE INTUBATING CONDITIONS AFTER PRIMING WITH VECURONIUM
    HELBOHANSEN, S
    RAVLO, O
    TRAPANDERSEN, S
    ACTA ANAESTHESIOLOGICA SCANDINAVICA, 1988, 32 (01) : 41 - 44
  • [9] PHARMACOKINETICS AND PHARMACODYNAMICS OF DIFFERENT DOSES OF IRTEMAZOLE IN REPEATED APPLICATION
    KAMILLI, I
    GRESSER, U
    ZOLLNER, N
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 1991, 50 (01): : 23 - 28
  • [10] PHARMACODYNAMICS AND URINE PHARMACOKINETICS OF 3 DOSES OF PIRETANIDE
    MEYER, BH
    MULLER, FO
    GRIGOLEIT, HG
    DAGROSA, EE
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 25 (06) : 783 - 785